Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.10
+0.30 (0.91%)
Apr 29, 2026, 1:17 PM CST

Sofiva Genomics Revenue

In the year 2025, Sofiva Genomics had annual revenue of 385.71M TWD, down -14.91%. Sofiva Genomics had revenue of 95.69M in the quarter ending December 31, 2025, a decrease of -7.52%.

Revenue
385.71M
Revenue Growth
-14.91%
P/S Ratio
1.84
Revenue / Employee
n/a
Employees
104
Market Cap
708.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025385.71M-67.61M-14.91%
Dec 31, 2024453.31M-13.49M-2.89%
Dec 31, 2023466.80M-28.98M-5.84%
Dec 31, 2022495.78M-12.64M-2.49%
Dec 31, 2021508.42M19.55M4.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puriblood Medical 117.35M
Kim Forest Enterprise 549.14M
Pharmigene 149.25M
Genetics Generation Advancement 603.11M
Welgene Biotech 375.94M
DIVA Laboratories 868.84M
BIONET 1.24B
Revenue Rankings